Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
Gross profit (GAAP) -- $2.7 million or 43.7% of revenue, compared to $2.2 million or 36.2% of revenue year over year, ...
We listed the NFL's top 25 pending free agents -- including Daniel Jones and George Pickens -- and gave intel on who might ...
Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...
Q1 2026 Earnings Call November 19, 2025 8:00 AM ESTCompany ParticipantsMartin Beer - CFO & Member of Management ...
How India’s political landscape has shifted from overt communal mobilisation to a deeper corporate-authoritarian order.
Zacks Small Cap Research on MSN
RANI: Third Quarter Results
RANI READ THE FULL RANI RESEARCH REPORT On November 6th, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) reported third ...
24/7 Wall St. on MSN
Nebius Stock Keeps Falling. Here’s Why You Should Be a Buyer
Nebius Group (NASDAQ:NBIS) was pulled out of obscurity earlier this year when Nvidia (NASDAQ:NVDA) revealed its hidden ...
Objective To estimate the efficacy of exercise on depressive symptoms compared with non-active control groups and to determine the moderating effects of exercise on depression and the presence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback